TransUnion
TRU NYSE Research & Consulting Services Financials FY2016βFY2025
TransUnion's revenue rose 9.4% to $4.6 billion in fiscal 2025. Its operating margin was 18.7%, up from 15.9% a year earlier. Free cash flow was $662 million, up 28.0%. It paid out $392 million in dividends and buybacks, 59% of free cash flow.
What TransUnion does
No business description yet.
- Legal name
- TransUnion
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001552033-26-000012
0001552033
Revenue and margins
TransUnion had $4.6B of revenue in fiscal 2025, up 9.4% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 15.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $662M in fiscal 2025, 14.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
TransUnion returned $393M to shareholders in fiscal 2025, 59% of free cash flow. The diluted share count fell 0.1%.
Value TransUnion yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$4.2B and divides by 196.6M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 22.6x Β· peers 29.6x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably TransUnion can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.8B | $588M | $479M | $682M | $856M |
| Debt incl. finance leases | $6.4B | $5.7B | $5.3B | $5.1B | $5.1B |
| Net debt / EBITDA | 4.4x | 4.4x | 7.5x | 3.7x | 3.0x |
| Debt / equity | 1.6x | 1.4x | 1.3x | 1.2x | 1.2x |
| Interest coverage | 5.8x | 2.7x | 0.5x | 2.5x | 3.6x |
| Current ratio | 1.9x | 1.6x | 1.5x | 1.7x | 1.8x |
| Quick ratio | 1.9x | 1.6x | 1.5x | 1.7x | 1.8x |
| Total assets | $12.6B | $11.7B | $11.1B | $11.0B | $11.1B |
| Total liabilities | $8.6B | $7.4B | $7.0B | $6.7B | $6.6B |
| Shareholders' equity | $3.9B | $4.2B | $4.0B | $4.2B | $4.4B |
| Net debt (β = net cash) | $4.5B | $5.1B | $4.9B | $4.5B | $4.2B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$5.1M
6 insiders
Of sales under plans
65%
$3.3M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 16, 2026 | Mohamed AbdelsadekEVP, Chief Global Solutions | Sold plan | 397 | $75.00 | $0.0M | Form 4 |
| Oct 15, 2026 | Mohamed AbdelsadekEVP, Chief Global Solutions | Sold plan | 500 | $70.00 | $0.0M | Form 4 |
| Oct 15, 2026 | Steven M ChaoukiPresident, US Markets | Sold plan | 1,000 | $70.00 | $0.1M | Form 4 |
| Sep 14, 2026 | Mohamed AbdelsadekEVP, Chief Global Solutions | Sold plan | 1,250 | $79.07 | $0.1M | Form 4 |
| Sep 10, 2026 | Venkat AchantaEVP, Chief Tech, Data & Analy. | Sold | 23,287 | $77.00 | $1.8M | Form 4 |
| Sep 1, 2026 | Steven M ChaoukiPresident, US Markets | Sold plan | 1,000 | $84.42 | $0.1M | Form 4 |
| Aug 31, 2026 | Jennifer A. WilliamsSVP, Chief Accounting Officer | Sold plan | 1,070 | $84.57 | $0.1M | Form 4 |
| Aug 11, 2026 | Alicia Brooke ZuikerEVP, CHRO | Sold plan | 8,673 | $78.49 | $0.7M | Form 4 |
| Aug 3, 2026 | Steven M ChaoukiPresident, US Markets | Sold plan | 1,000 | $79.96 | $0.1M | Form 4 |
| Aug 3, 2026 | Todd C. SkinnerPresident, International | Sold plan | 950 | $79.96 | $0.1M | Form 4 |
| Jul 28, 2026 | Mohamed AbdelsadekEVP, Chief Global Solutions | Sold plan | 23,495 | $85.00 | $2.0M | Form 4 |
| Jul 7, 2026 | Jennifer A. WilliamsSVP, Chief Accounting Officer | Sold plan | 972 | $80.00 | $0.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 3 / 8 | 7 / 8 | 8 / 8 |
| Accruals ratio | β7.5% | β5.0% | β4.8% |
| Altman Z'' | 1.61 | 2.23 | 2.55 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| TransUnion TRU | $15.8B | 9.4% | 18.7% | 14.5% | 7.1% | 22.6x | 8 | |
| FTI Consulting FCN | $4.6B | 2.4% | 10.3% | 2.5% | 16.6% | 18.9x | 4 | Compare β |
| Equifax EFX | $21.5B | 6.9% | 18.0% | 18.7% | 8.5% | 29.5x | 6 | Compare β |
| Verisk Analytics VRSK | $26.5B | 6.6% | 43.7% | 38.8% | 35.5% | 29.8x | 7 | Compare β |
| UL Solutions ULS | $15.0B | 6.4% | 17.1% | 13.2% | 26.8% | 29.6x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.7B | $1.9B | $2.3B | $2.5B | $2.5B | $3.0B | $3.7B | $3.8B | $4.2B | $4.6B |
| Gross profit | $1.1B | $1.3B | $1.5B | $1.6B | β | β | β | β | β | β |
| Operating income | $301M | $465M | $513M | $542M | $500M | $652M | $626M | $129M | $667M | $858M |
| Interest expense | $85.5M | $87.6M | $138M | $174M | $126M | $113M | $231M | $288M | $265M | $236M |
| Pretax income | $205M | $373M | $344M | $375M | $390M | $506M | $383M | β$145M | $401M | $643M |
| Income tax | $74.0M | β$79.1M | $54.5M | $70.5M | $83.7M | $132M | $119M | $44.7M | $98.8M | $173M |
| Net income | $121M | $441M | $277M | $347M | $343M | $1.4B | $266M | β$206M | $284M | $455M |
| Diluted EPS | $0.65 | $2.32 | $1.45 | $1.81 | $1.79 | $7.20 | $1.38 | β$1.07 | $1.45 | $2.32 |
| Diluted shares | 0.18B | 0.19B | 0.19B | 0.19B | 0.19B | 0.19B | 0.19B | 0.19B | 0.20B | 0.20B |
| Cash flow | ||||||||||
| Cash from operations | $390M | $466M | $556M | $777M | $788M | $808M | $297M | $645M | $833M | $988M |
| Capital expenditure | $124M | $135M | $180M | $188M | $206M | $224M | $298M | $311M | $316M | $326M |
| Free cash flow | $266M | $331M | $376M | $589M | $582M | $584M | β$1.0M | $335M | $517M | $662M |
| Depreciation and amortization | $265M | $238M | $307M | $339M | $347M | $377M | $519M | $524M | $538M | $575M |
| Stock-based compensation | $24.4M | $33.1M | $57.9M | $48.3M | $44.3M | $69.2M | $82.8M | $100M | $121M | $146M |
| Acquisitions | $357M | $343M | $1.8B | $22.3M | $57.9M | $3.6B | $508M | $0.0M | $0.0M | $55.7M |
| Share buybacks | $0.7M | $134M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $302M |
| Dividends paid | $0.0M | $0.0M | $41.6M | $56.8M | $57.6M | $69.8M | $77.8M | $81.8M | $82.7M | $90.5M |
| Dividends and buybacks | $0.7M | $134M | $41.6M | $56.8M | $57.6M | $69.8M | $77.8M | $81.8M | $82.7M | $393M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $186M | $119M | $190M | $277M | $496M | $1.8B | $588M | $479M | $682M | $856M |
| Total debt | $2.4B | $2.5B | $4.0B | $3.7B | $3.5B | $6.4B | $5.7B | $5.3B | $5.1B | $5.1B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.3M | $0.2M | $0.2M | $0.1M | $0.1M | $0.0M | $0.0M |
| Current assets | $550M | $589M | $842M | $888M | $1.5B | $2.6B | $1.5B | $1.5B | $1.8B | $2.0B |
| Current liabilities | $373M | $458M | $549M | $571M | $670M | $1.4B | $906M | $1.0B | $1.1B | $1.2B |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $198M | $199M | $220M | $219M | $220M | $248M | $218M | $199M | $204M | $258M |
| Total assets | $4.8B | $5.1B | $7.0B | $7.1B | $7.3B | $12.6B | $11.7B | $11.1B | $11.0B | $11.1B |
| Total liabilities | $3.3B | $3.3B | $5.1B | $4.8B | $4.7B | $8.6B | $7.4B | $7.0B | $6.7B | $6.6B |
| Shareholders' equity | $1.4B | $1.7B | $1.9B | $2.2B | $2.5B | $3.9B | $4.2B | $4.0B | $4.2B | $4.4B |
| Margins | ||||||||||
| Gross margin | 66.0% | 66.6% | 65.9% | 64.5% | β | β | β | β | β | β |
| Operating margin | 17.6% | 24.0% | 22.1% | 22.0% | 19.8% | 22.0% | 16.9% | 3.4% | 15.9% | 18.7% |
| EBITDA margin | 33.2% | 36.3% | 35.4% | 35.7% | 33.5% | 34.8% | 30.9% | 17.0% | 28.8% | 31.3% |
| Net margin | 7.1% | 22.8% | 11.9% | 14.1% | 13.6% | 47.0% | 7.2% | β5.4% | 6.8% | 10.0% |
| FCF margin | 15.6% | 17.1% | 16.2% | 23.9% | 23.0% | 19.7% | β0.0% | 8.7% | 12.4% | 14.5% |
| Returns | ||||||||||
| Return on capital | 5.4% | 11.9% | 8.6% | 7.6% | 6.9% | 6.8% | 4.8% | 1.1% | 5.7% | 7.1% |
| Return on capital employed | 7.0% | 10.3% | 9.2% | 8.3% | 7.6% | 7.3% | 5.7% | 1.2% | 6.7% | 8.6% |
| Return on equity | 9.3% | 28.5% | 15.3% | 16.8% | 14.3% | 43.1% | 6.6% | β5.0% | 6.9% | 10.5% |
| Return on assets | 2.6% | 8.9% | 4.6% | 4.9% | 4.8% | 13.9% | 2.2% | β1.8% | 2.6% | 4.1% |
| Growth | ||||||||||
| Revenue growth | β | 13.4% | 19.8% | 6.3% | 2.7% | 17.0% | 25.3% | 3.3% | 9.2% | 9.4% |
| Net income growth | 1,944.1% | 265.8% | β37.3% | 25.4% | β1.1% | 305.1% | β80.9% | β177.4% | β | 60.1% |
| EPS growth | 1,525.0% | 256.9% | β37.5% | 24.8% | β1.1% | 302.2% | β80.8% | β177.5% | β | 60.0% |
| FCF growth | 50.3% | 24.3% | 13.7% | 56.7% | β1.1% | 0.4% | β100.2% | β | 54.4% | 28.0% |
| Share count change | 10.7% | 2.9% | 0.5% | 0.5% | 0.2% | 0.4% | 0.1% | 0.2% | 1.7% | β0.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | 3.9x | 3.3x | 4.7x | 3.8x | 3.5x | 4.4x | 4.4x | 7.5x | 3.7x | 3.0x |
| Debt / equity | 1.7x | 1.4x | 2.1x | 1.6x | 1.4x | 1.6x | 1.4x | 1.3x | 1.2x | 1.2x |
| Interest coverage | 3.5x | 5.3x | 3.7x | 3.1x | 4.0x | 5.8x | 2.7x | 0.5x | 2.5x | 3.6x |
| Current ratio | 1.5x | 1.3x | 1.5x | 1.6x | 2.2x | 1.9x | 1.6x | 1.5x | 1.7x | 1.8x |
| Quick ratio | 1.5x | 1.3x | 1.5x | 1.6x | 2.2x | 1.9x | 1.6x | 1.5x | 1.7x | 1.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 7.3% | 7.0% | 7.8% | 7.7% | 8.1% | 7.6% | 8.0% | 8.1% | 7.6% | 7.1% |
| Stock comp / revenue | 1.4% | 1.7% | 2.5% | 2.0% | 1.8% | 2.3% | 2.2% | 2.6% | 2.9% | 3.2% |
| Payouts / FCF | 0.3% | 40.4% | 11.1% | 9.7% | 9.9% | 12.0% | β | 24.4% | 16.0% | 59.3% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 7.0 | 5.0 | 5.0 | 6.0 | 4.0 | 4.0 | 3.0 | 7.0 | 8.0 |
| Altman Z'' | 0.9 | 1.5 | 1.3 | 1.6 | 2.2 | 2.1 | 2.0 | 1.6 | 2.2 | 2.6 |
| Accruals ratio | β5.8% | β0.5% | β4.6% | β6.1% | β6.2% | 5.8% | β0.3% | β7.5% | β5.0% | β4.8% |
Source: SEC EDGAR XBRL filings (CIK 0001552033). Data updated October 12, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.